Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 67 (2), 151-9

Therapeutic Insulins and Their Large-Scale Manufacture

Affiliations
Review

Therapeutic Insulins and Their Large-Scale Manufacture

Gary Walsh. Appl Microbiol Biotechnol.

Abstract

Biotechnological innovations over the past 25 years have underpinned the rapid development of a thriving biopharmaceutical sector. Therapeutic insulin remains one of the most commonly used products of pharmaceutical biotechnology and insulin-based products command annual global sales in excess of $4.5 billion. Innovations in its method of production and in particular the advent of engineered insulin analogues provide a fascinating insight into how scientific and technological advances have impacted upon the pharmaceutical biotechnology sector as a whole. Current insulin-based diabetes research is increasingly focused not on the insulin molecule per se, but upon areas such as the development of non-parenteral insulin delivery systems, as well as organ-/cell-based and gene therapy-based approaches to controlling the disease.

Similar articles

  • The New Insulins
    S Crotty et al. Pediatr Emerg Care 23 (12), 903-5; quiz 906-7. PMID 18091602. - Review
    Diabetes is a growing problem for a large proportion of children. Insulin is the primary medication used for most cases of pediatric diabetes, though achieving adequate g …
  • Recombinant-DNA-derived Insulin Analogues as Potentially Useful Therapeutic Agents
    AF Bristow. Trends Biotechnol 11 (7), 301-5. PMID 7763953. - Review
    Whilst insulin is a spectacularly successful drug for the management of diabetes mellitus, it remains difficult to mimic the physiological pattern of insulin secretion, e …
  • [Development of Antituberculous Drugs: Current Status and Future Prospects]
    H Tomioka et al. Kekkaku 81 (12), 753-74. PMID 17240921. - Review
    Worldwide, tuberculosis (TB) remains the most frequent and important infectious disease causing morbidity and death. One-third of the world's population is infected with …
  • Biopharmaceuticals in China
    X Hu et al. Biotechnol J 1 (11), 1215-24. PMID 17089435. - Review
    The biopharmaceutical industry, whose products are produced mainly by recombinant DNA technology, antibody technologies and cytotechnology, is the most important sector i …
  • Recombinant Human Insulin
    MR Ladisch et al. Biotechnol Prog 8 (6), 469-78. PMID 1369033. - Review
    Insulin is a well-characterized peptide that can be produced by recombinant DNA technology for human therapeutic use. A brief overview of insulin production from both tra …
See all similar articles

Cited by 20 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources

Feedback